Journal: The EMBO Journal
Article Title: Tension-sensitive LINC-RhoA signaling prevents chromatin bridge breakage in cytokinesis
doi: 10.1038/s44318-025-00565-3
Figure Lengend Snippet: ( A , B ) RhoA localization in control BE cells or cells transfected with Sun1/2 siRNA (siSun1/2). Intact arrows indicate actin patches and/or canal bases. Broken arrows indicate broken DNA bridges. Scale bars, 5 μm. ( C ) RhoA intensity. Mean ± SD from n cells from two independent experiments. Values in control were set to 1. *** P = 1.01E-35 (control vs siSun1/2), 1.45E-38 (control vs siSun1/2 intact bridges) by ANOVA and Student’s t test. ( D ) Western blot analysis of total RhoA or α-tubulin (α-tub). ( E ) Actin patches intensity in GFP-positive cells. Cells were transfected with GFP:RhoA-G14V or GFP in the absence (control) or presence of siSun1/2. Mean ± SD from n cells from two independent experiments. Values in control GFP were set to 1. *** P = 2.83E-36 (control GFP vs GFP+siSun1/2), 1.79E-36 (GFP+siSun1/2 vs GFP:RhoA-G14V+siSun1/2) by ANOVA and Student’s t test. ( F ) Percentage of broken DNA bridges in GFP-positive cells. Mean ± SD from three independent experiments ( n = 125, 73, 83, 85). *** P = 0.00029; ** P = 0.0051 by ANOVA and Student’s t test. ( G ) Cartoons of Nesprin-2, mini-Nesprin-2 CB and CH* proteins. SRs spectrin repeats, ONM outer nuclear membrane, CH calponin homology. ( H ) Nuclear chromatin shape in cells expressing mini-Nesprin-2 CB or CH* proteins in the absence or presence of Nesprin-2 siRNA (siNesprin-2). Mean ± SD from n cells from two independent experiments. *** P = 1.01E-24 (interphase no bridges vs control GFP), 1.33E-07 (interphase no bridges vs GFP+siNesprin-2), 3.46E-06 (interphase no bridges vs CH*+siNesprin-2), 2.63E-06 (control GFP vs GFP+siNesprin-2), 5.98E-05 (GFP+siNesprin-2 vs CB+siNesprin-2), 5.92E-05 (CB+siNesprin-2 vs CH*+siNesprin-2) by ANOVA and Student’s t test. ( I ) Percentage of cells exhibiting Sun2 nuclear lines. Mean ± SD from three independent experiments ( n = 215, 64, 52, 65). ** P = 0.0062 (interphase no bridges vs CH*+siNesprin-2), 0.0018 (CB+siNesprin-2 vs CH*+siNesprin-2) by ANOVA and Student’s t test. ( J ) Percentage of intact loose DNA bridges in GFP- or YFP-positive cells. Mean ± SD from three independent experiments ( n = 143, 70, 102, 107). *** P = 0.00016 (control GFP vs GFP+siNesprin-2), 1.27E-05 (CB+siNesprin-2 vs CH*+siNesprin-2); ** P = 0.0035 by ANOVA and Student’s t test. ( K ) Chromatin bridges and actin patches in cells expressing mini-Nesprin-2 CB. ( L ) Actin patches intensity in GFP- or YFP-positive cells. Values in control GFP were set to 1. Mean ± SD from n cells from two independent experiments. *** P = 4.97E-88 (control GFP vs GFP+siNesprin-2), 1.05E-83 (control GFP vs CB+siNesprin-2), 1.63E-93 (control GFP vs CH*+siNesprin-2) by ANOVA and Student’s t test. ( M ) Percentage of broken DNA bridges in GFP- or YFP-positive cells. Mean ± SD from four independent experiments ( n = 125, 92, 84, 107). *** P = 3.83E-06 (control GFP vs GFP+siNesprin-2), 1.34E-06 (control GFP vs CB+siNesprin-2), 0.00072 (control GFP vs CH*+siNesprin-2); ** P = 0.009 (GFP+siNesprin-2 vs CB+siNesprin-2), 0.0079 (CB+siNesprin-2vs CH*+siNesprin-2) by ANOVA and Student’s t test. ( N , O ) Chromatin bridges and actin patches in cells expressing mini-Nesprin-2 CH* protein. Intact arrows indicate actin patches and/or canal bases. Broken arrows indicate broken DNA bridges. Insets show high magnifications of the canal bases. Scale bars, 5 μm. ( P ) Nuclear chromatin shape in cells transfected with Lamin A/C siRNA (siLamin A/C), or as in ( A , B ). Mean ± SD from n cells from two independent experiments. *** P = 1.28E-05 (interphase no bridges vs siLaminA/C), 4.44E-12 (control vs siLaminA/C) by ANOVA and Student’s t test. ( Q ) Percentage of intact loose DNA bridges. Mean ± SD from three independent experiments ( n = 188, 77). *** P = 0.00021 by ANOVA and Student’s t test. ( R ) Front/back Nesprin-2 intensity. Mean ± SD from n cells from two independent experiments. *** P = 4.34E-21 (interphase no bridges vs siRhoA), 1.24E-15 (control vs siLaminA/C) by ANOVA and Student’s t test. ( S ) Actin patches intensity. Mean ± SD from n cells from two independent experiments. Values in control were set to 1. Numbers below/next to each bar indicate n . *** P = 8.75E-56 by Student’s t test. .
Article Snippet: Human RhoA (sc-29471; 5’-GGCAGAGAUAUGGCAAACA-3’), p115 RhoGEF (sc-41734; a pool of three individual siRNAs: 5’-CUGGAGGAGAUGCAACAUA-3’, 5’-CCAAGAGUGGAGACAAGAA-3’, 5’-CCGAUCACAAAGCCUUCUA-3’), PDZ RhoGEF (sc-45823; a pool of three individual siRNAs: 5’-GAACCUGCCUGAACUCAUA-3’, 5’-CAAGAGCCUGGAUCUUACA-3’, 5’-CCUCAGACAUGCAAGUGAA-3’), LARG RhoGEF (sc-41800; a pool of three individual siRNAs: 5’-GGAUGGAGCUGUAGUUACA-3’, 5’-CCAGAGCAUUGAAUUACUA-3’, 5’-CGAAGGAGAUAAUGAUGAA-3’), Sun1 (sc-106672; a pool of three individual siRNAs: 5’-GGAUGCCGUACAAGAAAGA-3’, 5’-GUAACUGCUGGGCAUUUAA-3’, 5’-CAAGGCACUUAAAGUGUUA-3’), Sun2 (sc-76612; a pool of three individual siRNAs: 5’-GGAAAUCCAGCAACAUGAA-3’, 5’-GACGUAUGGUGCUUGGUAU-3’, 5’-GCAUCAGCAAGACUCAGAA-3’), Nesprin-2 (Syne-2; sc-61630; a pool of three individual siRNAs: 5’-GGUAGAACGUCAACCUCAA-3’, 5’-CAAACAGCCUUCUCAUUAA-3’, 5’-GACUUCUGUUGUACUGAAA-3’), Lamin A/C (sc-35776, 5’-CUGGACUUCCAGAAGAACA-3’), PDZ-2 (5’-GAACCUGCCUGAACUCAUA-3’) and c-Src (sc-29228, 5’-GCAGUUGUAUGCUGUGGUU-3’) siRNAs were from Santa Cruz Biotechnology.
Techniques: Control, Transfection, Western Blot, Membrane, Expressing